Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression

• Andrés Felipe Cardona ,

  Contributed equally to this work with: Andrés Felipe Cardona, Leonardo Rojas, Beatriz Wills, Oscar Arrieta

  * E-mail: andres.cardona@clinicadelcountry.com; a_cardonaz@yahoo.com

  Affiliations Clinical and Translational Oncology Group, Thoracic Oncology Unit, Institute of Oncology, Clínica del Country, Bogotá, Colombia, Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia

  ⨯
• Leonardo Rojas ,

  Contributed equally to this work with: Andrés Felipe Cardona, Leonardo Rojas, Beatriz Wills, Oscar Arrieta

  Affiliations Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia, Clinical Oncology Department, Centro Javeriano de Oncología, Hospital Universitario San Ignacio, Bogotá, Colombia

  ⨯
• Beatriz Wills ,

  Contributed equally to this work with: Andrés Felipe Cardona, Leonardo Rojas, Beatriz Wills, Oscar Arrieta

  Affiliations Clinical and Translational Oncology Group, Thoracic Oncology Unit, Institute of Oncology, Clínica del Country, Bogotá, Colombia, Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia

  ⨯
• Oscar Arrieta ,

  Contributed equally to this work with: Andrés Felipe Cardona, Leonardo Rojas, Beatriz Wills, Oscar Arrieta

  Affiliation Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), México City, México

  ⨯
• Hernán Carranza,

  Affiliations Clinical and Translational Oncology Group, Thoracic Oncology Unit, Institute of Oncology, Clínica del Country, Bogotá, Colombia, Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia

  ⨯
• Carlos Vargas,

  Affiliations Clinical and Translational Oncology Group, Thoracic Oncology Unit, Institute of Oncology, Clínica del Country, Bogotá, Colombia, Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia

  ⨯
• Jorge Otero,

  Affiliations Clinical and Translational Oncology Group, Thoracic Oncology Unit, Institute of Oncology, Clínica del Country, Bogotá, Colombia, Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia

  ⨯
• Mauricio Cuello,

  Affiliation Clinical Oncology Department, Hospital de Clínicas–UdeLAR, Montevideo, Uruguay

  ⨯
• Luis Corrales,

  Affiliation Clinical Oncology Department, Hospital San Juan de Dios, San José, Costa Rica

  ⨯
• Claudio Martín,

  Affiliation Thoracic Oncology Unit, Alexander Fleming Institute, Buenos Aires, Argentina

  ⨯
• Carlos Ortiz,

  Affiliation Clinical and Translational Oncology Group, Thoracic Oncology Unit, Institute of Oncology, Clínica del Country, Bogotá, Colombia

  ⨯
• Sandra Franco,

  Affiliation Clinical and Translational Oncology Group, Thoracic Oncology Unit, Institute of Oncology, Clínica del Country, Bogotá, Colombia

  ⨯
• Rafael Rosell,

  Affiliation Medical Oncology Department, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain

  ⨯
• CLICaP

  ¶Membership of CLICAP is provided in the Acknowledgments.

  ⨯